insights_auto
Why is VRAX down 3.79%?
Dive Deeperchevron_right
VRAX:NASDAQ
Virax Biolabs Group Ltd
$2.03
arrow_downward
-3.79%(-0.080) 1D
Oct 8, 9:46:43 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRAX...
Open
$2.13
High
$2.13
Low
$1.98
Mkt. cap
2.69M
Avg. vol.
149.66K
Volume
14.45K
52-wk high
$21.75
52-wk low
$1.83
EPS
-$12.64
Beta
1.40
Shares outstanding
1.34M
No. of employees
26
Open
$2.13
High
$2.13
Low
$1.98
Mkt. cap
2.69M
Avg. vol.
149.66K
Volume
14.45K
52-wk high
$21.75
52-wk low
$1.83
EPS
-$12.64
Beta
1.40
Shares outstanding
1.34M
No. of employees
26
News stories
From web sources and news partners
www.marketscreener.com
·
42 minutes ago
TruGolf Completes Acquisition of Polymath Research, Bringing a Blockchain Purpose-Built for Regulated Assets to Nasdaq
GlobeNewswire
·
1 hour ago
Primech Holdings (Nasdaq: PMEC) Subsidiary Earns 2026
markets.businessinsider.com
·
1 hour ago
Nexalin Technology Regains Compliance with Nasdaq Minimum Bid Price Requirement; Nasdaq Hearings Panel Grants Request for Continued Listing
qz.com
·
34 minutes ago
NYSE's Michael Reinking on record highs, treasury yields and market outlook
About Virax Biolabs Group Ltd
CEO-
Employees26
Founded2013
HeadquartersLondon, England, United Kingdom
SectorHealth care provider
Websiteviraxbiolabs.com